- Home
- WWR vs CPIX Comparison
WWR vs CPIX Comparison
Compare WWR & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWR
- CPIX
- Stock Information
- Founded
- WWR 1977
- CPIX 1999
- Country
- WWR United States
- CPIX United States
- Employees
- WWR N/A
- CPIX N/A
- Industry
- WWR Metal Mining
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- WWR Basic Materials
- CPIX Health Care
- Exchange
- WWR Nasdaq
- CPIX Nasdaq
- Market Cap
- WWR 48.0M
- CPIX 48.5M
- IPO Year
- WWR N/A
- CPIX 2009
- Fundamental
- Price
- WWR $0.76
- CPIX $3.23
- Analyst Decision
- WWR Strong Buy
- CPIX
- Analyst Count
- WWR 2
- CPIX 0
- Target Price
- WWR $2.00
- CPIX N/A
- AVG Volume (30 Days)
- WWR 1.2M
- CPIX 32.7K
- Earning Date
- WWR 11-14-2025
- CPIX 11-06-2025
- Dividend Yield
- WWR N/A
- CPIX N/A
- EPS Growth
- WWR N/A
- CPIX N/A
- EPS
- WWR N/A
- CPIX N/A
- Revenue
- WWR N/A
- CPIX $42,071,813.00
- Revenue This Year
- WWR N/A
- CPIX N/A
- Revenue Next Year
- WWR N/A
- CPIX N/A
- P/E Ratio
- WWR N/A
- CPIX N/A
- Revenue Growth
- WWR N/A
- CPIX 11.34
- 52 Week Low
- WWR $0.45
- CPIX $1.04
- 52 Week High
- WWR $1.32
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- WWR 56.01
- CPIX 43.51
- Support Level
- WWR $0.66
- CPIX $3.26
- Resistance Level
- WWR $0.82
- CPIX $3.57
- Average True Range (ATR)
- WWR 0.05
- CPIX 0.20
- MACD
- WWR -0.00
- CPIX -0.01
- Stochastic Oscillator
- WWR 62.50
- CPIX 2.13
About WWR Westwater Resources Inc.
Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.